Cointime

  • 最新情報
  • ニュース
  • 通貨
  • Columns
  • イベント
  • Bitcoin $64,636.06 +0.56%
  • Ethereum $1,911.23 +0.23%
  • BNB $602.44 -0.52%
  • Optimism $0.08 -1.62%
  • Arbitrum $0.08 -0.40%
  • Solana $76.91 +1.43%
  • Polygon $0.22 +2.77%
  • Cosmos $1.41 +0.07%
  • Avalanche $6.35 +0.45%
  • Bitcoin $64,636.06 +0.56%
  • Ethereum $1,911.23 +0.23%
  • BNB $602.44 -0.52%
  • Optimism $0.08 -1.62%
  • Arbitrum $0.08 -0.40%
  • Solana $76.91 +1.43%
  • Polygon $0.22 +2.77%
  • Cosmos $1.41 +0.07%
  • Avalanche $6.35 +0.45%
Home / Karyopharm Therapeutics / investors

Karyopharm Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
5
14
Karyopharm Therapeutics is funded by 14 investors. Avidity Partners and Foresite Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Avidity Partners Yes Post-IPO Equity
Foresite Capital Yes Series B
Chione Yes Series A
Multiple Myeloma Research Foundation Yes Grant
Adage Capital Management - Post-IPO Equity
Armistice Capital - Post-IPO Equity
HealthCor Partners - Post-IPO Equity
Heights Capital Management - Post-IPO Equity
Marshall Wace - Post-IPO Equity
Rubric Capital Management - Post-IPO Equity
SilverArc Capital - Post-IPO Equity
Surveyor Capital - Post-IPO Equity
Delphi Ventures - Series B
New Leaf Venture Partners - Series B

Contact

Newton,Massachusetts,United States
+1 617 658 0600
Cointime
Content
  • 最新情報
  • スタートアップ
  • 業界ニュース
  • テクノロジー
  • イベント
Company
  • 会社概要
  • 広告
  • 免責事項
  • © 2023 Cointime. 無断転載禁止
  • プライバシーポリシー
  • 利用規約